Predictors of Financial Toxicity in Patients Receiving Concurrent Radiation Therapy and Chemotherapy
2022 · Advances in Radiation Oncology · 10 citations
https://doi.org/10.1016/j.adro.2022.101141
R
Rafi Kabarriti
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
248
Papers
3.0K
Citations
25
h-index
48
i10-index
Rafi Kabarriti is an academic researcher from Albert Einstein College of Medicine. The author has contributed to research in topics: Head and Neck Cancer Studies & Advanced Radiotherapy Techniques & Hepatocellular Carcinoma Treatment and Prognosis. The author has an h-index of 25, co-authored 211 publications.
ORCID: 0000-0001-7835-718XPapers by this author
worksProton Therapy for Unresectable and Medically Inoperable Locally Advanced Pancreatic Cancer: Results From a Multi-Institutional Prospective Registry
2023 · Advances in Radiation Oncology · 5 citations
https://doi.org/10.1016/j.adro.2023.101250
Reirradiation With Proton Therapy for Recurrent Malignancies of the Esophagus and Gastroesophageal Junction: Results of the Proton Collaborative Group Multi-Institutional Prospective Registry Trial
2024 · Advances in Radiation Oncology · 4 citations
https://doi.org/10.1016/j.adro.2024.101459
Using Statistical Measures and Density Maps Generated From Chest Computed Tomography Scans to Identify and Monitor COVID-19 Cases in Radiation Oncology Rapidly
2021 · Cureus · 1 citations
https://doi.org/10.7759/cureus.17432
997: Impact of Treatment Package Time on Survival in Adenoid Cystic Carcinoma of the Head and Neck
2024 · Radiotherapy and Oncology · 0 citations
https://doi.org/10.1016/s0167-8140(24)01486-5
433: Randomized evaluation of the PET-adjusted IMRT for NSCLC Trial (REPAINT)
2024 · Radiotherapy and Oncology · 0 citations
https://doi.org/10.1016/s0167-8140(24)01052-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat